Neogenomics (NEO) Assets Average (2011 - 2026)

Neogenomics (NEO) has reported Assets Average for 16 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 9.9% year-over-year to $1.3 billion; the trailing twelve-month figure through Jun 2026 stood at $1.3 billion (down 9.9% YoY), and the FY2025 full-year result was $1.5 billion, down 9.68% from the prior year.
• Assets Average held at $1.3 billion in Q2 2026 per NEO's latest filing, from $1.4 billion in the prior quarter.
• Across five years, Assets Average topped out at $1.8 billion in Q1 2022 and bottomed at $1.3 billion in Q2 2026.
• Historically, Assets Average has averaged $1.6 billion across 5 years, with a median of $1.7 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Assets Average soared 49.0% in 2022, then decreased 16.61% in 2025.
• Over 5 years, Assets Average stood at $1.7 billion in 2022, then retreated by 3.89% to $1.7 billion in 2023, then slipped by 2.39% to $1.6 billion in 2024, then fell by 16.61% to $1.4 billion in 2025, then slipped by 1.31% to $1.3 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $1.3 billion, $1.4 billion, and $1.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.